D-Xone S represents a high-quality sterile pharmaceutical formulation combining ceftriaxone sodium and sulbactam sodium in precise USP equivalent concentrations. Manufactured under...

D-Xone S represents a high-quality sterile pharmaceutical formulation combining ceftriaxone sodium and sulbactam sodium in precise USP equivalent concentrations. Manufactured under stringent sterile conditions, this dry powder injection ensures consistent potency and reliability for critical medical applications. Available in two standardized strengths (250mg/125mg and 500mg/250mg), it provides healthcare professionals with a trusted antibiotic solution that meets rigorous quality standards for reconstitution and administration in clinical environments. The product's formulation addresses the growing need for effective antibiotic combinations in modern healthcare.

This combination antibiotic finds essential application across diverse healthcare sectors, particularly in hospital environments where severe bacterial infections demand immediate and effective treatment. Medical facilities including critical care units, emergency departments, surgical wards, and infectious disease specialties utilize this product as part of comprehensive infection management protocols. Pharmaceutical companies and distributors incorporate D-Xone S into their supply chains to provide healthcare providers with reliable antibiotic solutions that combat resistant bacterial strains while maintaining compliance with international regulatory standards for antibiotic medications.

The product delivers significant value through its proven reliability and consistent quality, ensuring customer satisfaction and repeat business for distributors and suppliers. Its adherence to international pharmaceutical standards facilitates smooth operations across global supply chains, while the sterile formulation minimizes contamination risks and enhances patient safety. The effectiveness of this antibiotic combination in treating serious infections strengthens the reputation of suppliers who provide high-quality pharmaceutical products to healthcare providers, creating long-term business relationships built on trust and performance.

Key Features:
- Sterile USP equivalent ceftriaxone sodium and sulbactam sodium formulation
- Available in two precise strength options: 250mg/125mg and 500mg/250mg
- Dry powder injection format designed for easy reconstitution and administration
- Manufactured under rigorous sterile conditions ensuring consistent potency
- Compliant with international pharmaceutical quality standards

Benefits:
- Provides effective treatment for severe bacterial infections requiring combination therapy
- Offers reliable performance with consistent quality across production batches
- Supports healthcare providers in managing antibiotic-resistant bacterial strains
- Minimizes contamination risks through sterile manufacturing processes
- Facilitates supply chain operations with standardized pharmaceutical packaging